News
SLBT
1.200
+2.56%
0.030
SL Science Reports Higher Revenue, Expands Gross Margin In First Half 2026
NASDAQ · 5d ago
SL Science Holding Limited Non-GAAP EPS of $0.00, revenue of $1.38B
Seeking Alpha · 6d ago
SL Science Holding Files Form 6-K Detailing First-Half 2026 Results
TipRanks · 6d ago
SL Science Holding H1 Sales $1.387M Up From $1.129M YoY
Benzinga · 6d ago
Weekly Report: what happened at SLBT last week (1019-1023)?
Weekly Report · 6d ago
Weekly Report: what happened at SLBT last week (1012-1016)?
Weekly Report · 10/19 10:29
Weekly Report: what happened at SLBT last week (1005-1009)?
Weekly Report · 10/12 10:36
Weekly Report: what happened at SLBT last week (0928-1002)?
Weekly Report · 10/05 10:35
Massive Insider Move Signals Bold Confidence at SL Science Holding Ltd
TipRanks · 10/02 02:00
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 09/28 21:06
Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday
Benzinga · 09/28 18:25
Weekly Report: what happened at SLBT last week (0921-0925)?
Weekly Report · 09/28 10:29
SL Science Reports Promising Targeting Of Cancer Cells By Gamma-Omega T Cells
NASDAQ · 09/27 12:25
SL Science Holding Adopts Cayman Islands Governance Exemptions on Nasdaq
TipRanks · 09/24 20:27
Weekly Report: what happened at SLBT last week (0914-0918)?
Weekly Report · 09/21 10:30
SL Science: A $1.15 Billion Valuation Built On Preclinical Promises
Seeking Alpha · 09/16 14:35
Weekly Report: what happened at SLBT last week (0907-0911)?
Weekly Report · 09/14 10:36
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 09/10 17:06
Weekly Report: what happened at SLBT last week (0831-0904)?
Weekly Report · 09/07 10:28
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/03 12:05
More
Webull provides a variety of real-time SLBT stock news. You can receive the latest news about SL Science Holding Ltd through multiple platforms. This information may help you make smarter investment decisions.
About SLBT
SL Science Holding Ltd is a Taiwan-based company mainly engaged in the research and development (R&D) of cell and gene therapies for cancer treatment and regenerative medicine. The Company develops investigational immune cell technologies, including gamma delta (γδ) T cells, Armed-T cells and exosome-based formulations, and operates through its biotechnology and oncology research activities.